CDISC And C-Path Formalize Agreement: Innovative Partnership To Address Major Neurodegenerative Diseases

The Critical Path Institute (C-Path) and the Clinical Data Interchange Standards Consortium (CDISC) have signed an agreement formalizing their collaborative efforts to establish new clinical data standards that will facilitate development of drugs for diseases like Alzheimer’s, Huntington’s , ALS, multiple sclerosis and possibly others. These efforts include streamlining the qualification process for disease biomarkers.

Click here to read more.

Share this: